Danaher's takeover interest of Catalent may be on the back burner: report
Danaher Life Sciences’ interest in contract manufacturer Catalent appears to have fizzled for the moment, according to Bloomberg News.
The life sciences conglomerate has stopped …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.